Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on‐demand therapy with activated factor VII in severe haemophilia A patients with …

R Villarrubia, I Oyagüez, MT Álvarez‐Román… - …, 2015 - Wiley Online Library
Objective: A cost analysis model was developed to compare annual cost of prophylaxis with
activated prothrombin complex concentrate (aPCC) vs. on‐demand therapy with activated …

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with …

R Villarrubia, I Oyagüez… - … : the Official Journal of …, 2015 - europepmc.org
Objective A cost analysis model was developed to compare annual cost of prophylaxis with
activated prothrombin complex concentrate (aPCC) vs. on-demand therapy with activated …

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with …

R Villarrubia, I Oyagüez, MT Álvarez‐Román… - …, 2015 - search.ebscohost.com
Objective: A cost analysis model was developed to compare annual cost of prophylaxis with
activated prothrombin complex concentrate (aPCC) vs. on-demand therapy with activated …

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with …

R Villarrubia, I Oyagüez… - … : the official journal …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective A cost analysis model was developed to compare annual cost of prophylaxis with
activated prothrombin complex concentrate (aPCC) vs. on-demand therapy with activated …

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on‐demand therapy with activated factor VII in severe haemophilia A patients with …

R Villarrubia, I Oyagüez, MT Álvarez‐Román… - Haemophilia, 2015 - infona.pl
Objective: A cost analysis model was developed to compare annual cost of prophylaxis with
activated prothrombin complex concentrate (aPCC) vs. on‐demand therapy with activated …